Non-invasive TI Stimulation for Temporal Lobe Epilepsy

(TI-HPC-TLE Trial)

MK
Overseen ByMatthew K Moye, BSc
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Duke University
Must be taking: Antiseizure medications
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores whether a new, non-invasive treatment called Temporal Interference (TI) Stimulation can reduce seizures and improve sleep in people with drug-resistant temporal lobe epilepsy. The treatment applies gentle electrical stimulation to the brain during sleep. Participants will spend several nights in a lab to determine if this approach lowers seizure activity and enhances sleep quality. This trial may suit those with long-standing temporal lobe epilepsy who haven't found relief with medication. Participants must be comfortable staying overnight in a lab for monitoring. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could lead to new treatment options.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop your current medications, but it requires that your antiseizure medication regimen is stable for at least one week before joining. It's best to discuss your specific situation with the trial team.

What prior data suggests that this non-invasive TI stimulation is safe for adults with temporal lobe epilepsy?

Research has shown that non-invasive temporal interference (TI) stimulation is generally safe for people. One study on TI stimulation's safety found it well-tolerated, with no serious side effects reported. Participants did not experience major problems with brain function or thinking abilities.

Another safety review of TI stimulation found that mild side effects, such as slight skin irritation, can occur, but these are usually minor and temporary. This method uses electrical currents to target specific brain areas without surgery, making it safer than more invasive treatments.

Overall, the safety data so far suggests that TI stimulation is a promising approach with a good safety record. However, as with any treatment, monitoring for side effects during the trial remains important.12345

Why are researchers excited about this trial?

Unlike the standard treatments for temporal lobe epilepsy, which often involve medications like antiepileptic drugs or invasive procedures like surgery, non-invasive Temporal Interference (TI) Stimulation offers a unique, non-invasive approach. This method uses targeted electrical stimulation to influence brain activity, specifically focusing on the bilateral hippocampi, without the need for surgery or implants. Researchers are excited about TI Stimulation because it has the potential to reduce seizures while minimizing side effects and risks associated with more invasive techniques. Additionally, this approach might offer a new way to monitor and improve cognitive and mood outcomes in patients with epilepsy.

What evidence suggests that non-invasive TI stimulation is effective for temporal lobe epilepsy?

Research has shown that non-invasive temporal interference (TI) stimulation can target the hippocampus, a brain region that helps control seizures. Studies have found that similar deep brain stimulation methods can reduce seizure frequency by affecting brain areas involved in seizures. Specifically, TI stimulation has lowered signals indicating seizure activity, known as epileptic biomarkers. This approach has proven effective in both animal studies and early human tests. In this trial, participants will undergo TI stimulation during overnight sessions. Initial results suggest that TI stimulation might help reduce seizures and improve sleep quality in people with temporal lobe epilepsy.12356

Who Is on the Research Team?

BF

Birgit Frauscher, MD / PD

Principal Investigator

Duke University

AW

Adam Williamson, PhD

Principal Investigator

St. Anne's University Hospital, Brno Czechia

Are You a Good Fit for This Trial?

This trial is for adults aged 18-70 with drug-resistant temporal lobe epilepsy who can stay in a sleep lab and have stable seizure medication. People can't join if they are pregnant, breastfeeding, have certain implants, severe mental illness, recent serious seizures, or untreated severe sleep apnea.

Inclusion Criteria

I am between 18 and 70 years old.
Candidate for in-laboratory overnight monitoring with PSG and scalp EEG, with ability to comply with study procedures
I have focal drug-resistant temporal lobe epilepsy.
See 2 more

Exclusion Criteria

Recent status epilepticus, seizure clusters requiring emergency intervention, or other features indicating unacceptable risk for monitored participation
Pregnancy or breastfeeding
Uncontrolled psychiatric illness (e.g., acute psychosis, severe untreated depression with high suicide risk)
See 5 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Baseline Monitoring

Participants undergo one night of monitoring without stimulation to establish baseline EEG and sleep patterns

1 night
1 in-lab overnight visit

Treatment

Participants receive TI stimulation during sleep for several nights to assess effects on EEG and sleep quality

3 nights
3 in-lab overnight visits

Post-Treatment Monitoring

Participants have another night of monitoring without stimulation to assess persistence of changes

1 night
1 in-lab overnight visit

Follow-up

Participants are monitored for safety, tolerability, and cognitive performance after the treatment phase

1 day
1 in-person follow-up visit

What Are the Treatments Tested in This Trial?

Interventions

  • Non-invasive Temporal Interference (TI) Stimulation

Trial Overview

The study tests overnight non-invasive brain stimulation (TI) targeting the hippocampus to see if it reduces abnormal brain activity linked to seizures and improves sleep. Participants experience both nights with and without stimulation while being monitored in a lab.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Single Group: Overnight TI Stimulation and Within-Subject No-Stimulation Control NightsExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Duke University

Lead Sponsor

Trials
2,495
Recruited
5,912,000+

St. Anne's University Hospital Brno, Czech Republic

Collaborator

Trials
37
Recruited
9,900+

Citations

Non-invasive temporal interference stimulation of the ... - PMC

DBS stimulation at 130–145Hz of either the hippocampus or ANT resulted in a reduction of seizure frequency [[10], [11], [12], [13], [14]], along with a decrease ...

Non-invasive temporal interference electrical stimulation of ...

In this Article, we aim to test the translation of these results by investigating the application of TI to the human hippocampus. Earlier human ...

Non-invasive Temporal Interference Stimulation of the ...

DBS stimulation at 130-145Hz of either the hippocampus or ANT resulted in a reduction of seizure frequency, along with a decrease in interictal ...

Focal non-invasive deep-brain stimulation with temporal ...

A non-invasive deep brain stimulation applied via temporal interference achieves to target the hippocampus in mice and human cadavers.

5.

pubmed.ncbi.nlm.nih.gov

pubmed.ncbi.nlm.nih.gov/41232758/

Non-invasive temporal interference stimulation of the ...

We investigated the potential of non-invasive temporal interference (TI) electrical stimulation in reducing epileptic biomarkers in patients ...

Colliding currents can target the deep brain without surgery

The new approach, called temporal interference (TI) stimulation, offered access to deep-brain areas previously only targetable with surgery.